Clinical and Imaging Biomarkers in Myotonic Dystrophy Type 2 (P2-11.022)
This study aims to characterize the imaging phenotype and utility of imaging biomarkers in DM2 using artificial intelligence-based (AI) muscle segmentation algorithms to analyze whole-body MRI scans.
Authors
- Lauren Hinkley (ORCID: https://orcid.org/0000-0003-1338-0383)
- Doris G. Leung (ORCID: https://orcid.org/0000-0002-2558-7798)
- Michael A. Jacobs (ORCID: https://orcid.org/0000-0002-1125-1644)
- Kathryn R. Wagner
Institutions
- Kennedy Krieger Institute (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211488
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00